DNAM-1仿真受体工程NK细胞:基于CAR-NK细胞的免疫疗法的新前沿
Loredana Cifaldi1, Ombretta Melaiu1, Roberto Giovannoni2
1Department of Clinical Sciences and Translational Medicine, University of Rome "Tor Vergata", Rome, Italy.
Frontiers in immunology
|June 26, 2023
概括
化学DNAM-1受体工程NK细胞提供了一种新的免疫治疗方法. 这种策略通过利用DNAM-1来增强针对性杀死癌细胞的能力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- DNAM-1 是一个关键的NK细胞受体,参与瘤和病毒感染细胞的消除.
- DNAM-1 结合了 PVR 和 Nectin-2 连接体,这些连接体存在于各种癌细胞和感染细胞上.
- 虽然存在其他工程NK细胞疗法,但DNAM-1工程NK细胞是最近的发展.
研究的目的:
- 介绍使用DNAM-1仿真受体工程NK细胞的理由.
- 探索这种新的方法作为一种潜在的抗癌免疫疗法.
主要方法:
- 这是一个视角研究,概述了一个理论方法.
- 它建立在最近对DNAM-1工程NK细胞的概念验证研究之上.
主要成果:
- 该研究侧重于理由和潜力,而不是经验结果.
- 它强调了DNAM-1工程NK细胞增强抗癌免疫力的潜力.
结论:
- DNAM-1工程NK细胞代表了癌症免疫治疗的有希望的新途径.
- 需要进一步开发以探索它们的临床应用.
更多相关视频
11:02Natural Killer NK and CAR-NK Cell Expansion Method using Membrane Bound-IL-21-Modified B Cell Line
Published on: February 8, 2022
5.7K
08:29Engineering Chimeric Antigen Receptor-Natural Killer Cells Targeting Fungal Infections Using the Non-viral Sleeping Beauty Transposon System
Published on: October 4, 2024
849
相关概念视频
01:27Cytotoxic T Cells-mediated Immune Response
998
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
998
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
208
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
208